Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin's Lymphomas: A Single Center Experience

被引:0
|
作者
Cai, Qingqing
Chen, Yiming
Zou, Dehui
Badillo, Maria
Zhou, Shouhao
Zhang, Liang
Lopez, Elyse R.
Jiang, Wenqi
Huang, Hui-qiang
Lin, Tongyu
Wang, Michael
机构
关键词
D O I
10.1182/blood.V122.21.3056.3056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3056
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma
    Cai, Qingqing
    Chen, Yiming
    Zou, Dehui
    Zhang, Liang
    Badillo, Maria
    Zhou, Shouhao
    Lopez, Elyse
    Jiang, Wenqi
    Huang, Huiqiang
    Lin, Tongyu
    Romaguera, Jorge
    Wang, Michael
    ONCOTARGET, 2014, 5 (17) : 7368 - 7380
  • [2] Relapsed Or Refractory Aggressive Non Hodgkin B-Cell Lymphomas Treated With Lenalidomide With/Without Rituximab Or Steroids: A Single Center Restrospective Study
    Castellino, Alessia
    Chiappella, Annalisa
    Ghione, Paola
    Ceccarelli, Manuela
    Benevolo, Giulia
    Botto, Barbara
    Caracciolo, Daniele
    Ciochetto, Chiara
    Nicolosi, Maura
    Orsucci, Lorella
    Pecoraro, Clara
    Pregno, Patrizia
    Riccomagno, Paola
    Zanni, Manuela
    Ladetto, Marco
    Vitolo, Umberto
    BLOOD, 2013, 122 (21)
  • [3] Rituximab for aggressive non-Hodgkin's lymphomas relapsing or refractory to autologous stem cell transplantation
    Pan, D
    Moskowitz, CH
    Zelenetz, AD
    Straus, D
    Kewalaramani, T
    Noy, A
    Qin, J
    Teruya-Feldstein, J
    Portlock, CS
    CANCER JOURNAL, 2002, 8 (05): : 371 - 376
  • [4] Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
    Changhee Park
    Ho Sup Lee
    Ka-Won Kang
    Won-Sik Lee
    Young Rok Do
    Jae-Yong Kwak
    Ho-Jin Shin
    Sung-Yong Kim
    Jun Ho Yi
    Sung-Nam Lim
    Jeong-Ok Lee
    Deok-Hwan Yang
    Hun Jang
    Byoungsan Choi
    Jiwoo Lim
    Choong Hyun Sun
    Ja Min Byun
    Sung-Soo Yoon
    Youngil Koh
    Nature Communications, 15
  • [5] Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
    Park, Changhee
    Lee, Ho Sup
    Kang, Ka-Won
    Lee, Won-Sik
    Do, Young Rok
    Kwak, Jae-Yong
    Shin, Ho-Jin
    Kim, Sung-Yong
    Yi, Jun Ho
    Lim, Sung-Nam
    Lee, Jeong-Ok
    Yang, Deok-Hwan
    Jang, Hun
    Choi, Byoungsan
    Lim, Jiwoo
    Sun, Choong Hyun
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [6] Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas
    Volpetti, Stefano
    Zaja, Francesco
    Fanin, Renato
    ONCOTARGETS AND THERAPY, 2014, 7 : 865 - 872
  • [7] Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas
    Khouri, IF
    Saliba, RM
    Hosing, C
    Okoroji, GJ
    Acholonu, S
    Anderlini, P
    Couriel, D
    De Lima, M
    Donato, ML
    Fayad, L
    Giralt, S
    Jones, R
    Korbling, M
    Maadani, F
    Manning, JT
    Pro, B
    Shpall, E
    Younes, A
    McLaughlin, P
    Champlin, RE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2240 - 2247
  • [8] Axicabtagene ciloleucel for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphomas
    Sharma, P.
    King, G. T.
    Shinde, S. S.
    Purev, E.
    Jimeno, A.
    DRUGS OF TODAY, 2018, 54 (03) : 187 - 198
  • [9] Salvage Therapy with Allogeneic Hematopoietic Cell Transplantation For Relapsed/Refractory Aggressive B-Cell Lymphomas: A Single-Center Experience
    Doerfel, D.
    Haen, S. P.
    Vogel, W.
    Kanz, L.
    Moehle, R.
    Wirths, S.
    Faul, C.
    Bethge, W. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S603 - S603
  • [10] The GMALL-B-ALL/NHL protocol is an effective salvage treatment in relapsed and refractory aggressive B-cell non-Hodgkin's lymphomas
    Sakarou, M.
    Duehrsen, U.
    Huettmann, A.
    ONKOLOGIE, 2012, 35 : 40 - 40